Copyright © 2026 OccupationalTherapy.com - All Rights Reserved

OccupationalTherapy.com Phone: 866-782-9924

Exam Preview

Evidence-Based Management of Patients On GLP-1 Therapy: An OT Perspective

View Course Details Please note: exam questions are subject to change.
Print

1.  Data collected in the United States from 2017 to 2020 revealed that the percentage of adults who were obese is?
  1. 19.7%
  2. 34.0%
  3. 41.9%
  4. 52.3%
2.  Which hormone is released by K-cells in the proximal small intestine after eating and has minimal or no clinically meaningful effect on gastric emptying?
  1. Glucagon-Like Peptide-1 (GLP-1)
  2. Glucose-Dependent Insulinotropic Polypeptide (GIP)
  3. Ghrelin
  4. Glucagon
3.  According to the 2025 AAOS study cited on Slide 30 under "Emerging Pre-Orthopedic Surgery Concerns," how many days prior to total joint replacement surgery is it recommended to discontinue GLP-1 medications?
  1. At least 3 days
  2. At least 7 days
  3. At least 14 days
  4. At least 30 days
4.  According to the U.S. Physical Activity Guidelines, what is the minimum recommended weekly duration of moderate-intensity aerobic physical activity for adults aged 18 to 64 years?
  1. 60 minutes
  2. 75 minutes
  3. 150 minutes
  4. 300 minutes
5.  To minimize lean mass loss during weight management, what is the recommended weekly weight loss target?
  1. ~1 to 2 lbs./week
  2. ~3 to 4 lbs./week
  3. ~5 to 6 lbs./week
  4. ~0.5 lb./month